Loading...
•
Sep 30, 2024
Privia Health Q3 2024 Earnings Report
Privia Health's financial performance for Q3 2024 was reported, demonstrating strong execution across business and financial metrics, and full-year 2024 guidance was raised.
Key Takeaways
Privia Health reported a 4.9% increase in total revenue, reaching $437.9 million. The company's adjusted EBITDA grew by 25.8% to $23.6 million, and cash and cash equivalents increased by 27.7% to $422.0 million. They also delivered MSSP 2023 Shared Saving of $176.6 Million, +34.1% versus 2023
Total revenue increased by 4.9% year-over-year to $437.9 million.
Adjusted EBITDA grew by 25.8% year-over-year to $23.6 million.
Cash and cash equivalents increased by 27.7% year-over-year to $422.0 million.
Announced New Market Entry in Indiana
Privia Health
Privia Health
Privia Health Revenue by Segment
Revenue by Segment
FFS Patient Care Revenue
CapyFin.comFFS Admin Services Revenue
CapyFin.comCapitated Revenue
CapyFin.comShared Savings Revenue
CapyFin.comCare Mgmt Fees (PMPM) Revenue
CapyFin.comOther Revenue
CapyFin.com Forward Guidance
Privia Health raised its full-year 2024 guidance to at or above the high end for all metrics.
Positive Outlook
- Implemented Providers: High End
- Attributed Lives: Above High End
- Practice Collections: High End
- GAAP Revenue: High End
- Adjusted EBITDA: High End
Revenue & Expenses
Visualization of income flow from segment revenue to net income